213 related articles for article (PubMed ID: 7772740)
1. Effects of chronic administration of adenosine antagonists on adenosine A1 and A2a receptors in mouse brain.
Traversa U; Rosati AM; Florio C; Vertua R
In Vivo; 1994; 8(6):1073-8. PubMed ID: 7772740
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
[TBL] [Abstract][Full Text] [Related]
3. Chronic carbamazepine down-regulates adenosine A2 receptors: studies with the putative selective adenosine antagonists PD115,199 and PD116,948.
Elphick M; Taghavi Z; Powell T; Godfrey PP
Psychopharmacology (Berl); 1990; 100(4):522-9. PubMed ID: 2157232
[TBL] [Abstract][Full Text] [Related]
4. 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors.
Vittori S; Camaioni E; Di Francesco E; Volpini R; Monopoli A; Dionisotti S; Ongini E; Cristalli G
J Med Chem; 1996 Oct; 39(21):4211-7. PubMed ID: 8863798
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
[TBL] [Abstract][Full Text] [Related]
6. Role of adenosine receptors in caffeine tolerance.
Holtzman SG; Mante S; Minneman KP
J Pharmacol Exp Ther; 1991 Jan; 256(1):62-8. PubMed ID: 1846425
[TBL] [Abstract][Full Text] [Related]
7. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
8. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.
Luthin DR; Olsson RA; Thompson RD; Sawmiller DR; Linden J
Mol Pharmacol; 1995 Feb; 47(2):307-13. PubMed ID: 7870039
[TBL] [Abstract][Full Text] [Related]
10. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.
Dalpiaz A; Gessi S; Varani K; Borea PA
Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770
[TBL] [Abstract][Full Text] [Related]
11. A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment.
Johansson B; Georgiev V; Lindström K; Fredholm BB
Brain Res; 1997 Jul; 762(1-2):153-64. PubMed ID: 9262169
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
13. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M
J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897
[TBL] [Abstract][Full Text] [Related]
14. Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.
Goodman RR; Cooper MJ; Gavish M; Snyder SH
Mol Pharmacol; 1982 Mar; 21(2):329-35. PubMed ID: 6285169
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J
J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
[TBL] [Abstract][Full Text] [Related]
17. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
[TBL] [Abstract][Full Text] [Related]
18. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity in mice.
Florio C; Rosati AM; Traversa U; Vertua R
Life Sci; 1997; 60(17):1477-86. PubMed ID: 9126868
[TBL] [Abstract][Full Text] [Related]
20. Binding thermodynamics of adenosine A2a receptor ligands.
Borea PA; Dalpiaz A; Varani K; Guerra L; Gilli G
Biochem Pharmacol; 1995 Feb; 49(4):461-9. PubMed ID: 7532939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
